Y-Intercept (HK)’s BioNTech BNTX Stock Holding History

Y-Intercept (HK)’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$430K	Buy	+4,623	New	+$435K	0.01%	1355
2024 Q4	–	Sell	-6,046	Closed	-$718K	–	1207
2024 Q3	$718K	Buy	+6,046	New	+$556K	0.04%	595
2024 Q1	–	Sell	-11,696	Closed	-$1.23M	–	1381
2023 Q4	$1.23M	Buy	+11,696	New	+$1.18M	0.11%	249
2022 Q4	–	Sell	-4,010	Closed	-$541K	–	1015
2022 Q3	$541K	Sell	4,010 -26,790	-87%	-$4.1M	0.05%	503
2022 Q2	$4.59M	Buy	+30,800	New	+$4.71M	0.6%	20
2022 Q1	–	Sell	-1,003	Closed	-$259K	–	729
2021 Q4	$259K	Sell	1,003 -5,258	-84%	-$1.44M	0.06%	439
2021 Q3	$1.71M	Buy	+6,261	New	+$1.99M	0.31%	88

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Y-Intercept (HK)'s BNTX Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in BioNTech (BNTX) in Q2 2026: 4,623 shares worth $430K. The stake represents 0.01% of the portfolio and ranks #1355 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in BNTX as recently as Q3 2024.

Y-Intercept (HK) first reported a position in BNTX in Q3 2021 and has held it in 7 quarters since. The position peaked at $4.59M in Q2 2022. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Y-Intercept (HK) held 4,623 shares of BioNTech worth $430K as of Q2 2026.
BioNTech was a new Y-Intercept (HK) position in Q2 2026.
BioNTech made up 0.01% of Y-Intercept (HK)'s portfolio in Q2 2026, its #1355 holding.
Y-Intercept (HK) first reported a position in BioNTech in Q3 2021 and has held it in 7 quarters since.
Y-Intercept (HK)'s BioNTech position peaked at $4.59M in Q2 2022.
283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.